CA1058519A - Anticonvulsant diphenylsilanes - Google Patents
Anticonvulsant diphenylsilanesInfo
- Publication number
- CA1058519A CA1058519A CA252,085A CA252085A CA1058519A CA 1058519 A CA1058519 A CA 1058519A CA 252085 A CA252085 A CA 252085A CA 1058519 A CA1058519 A CA 1058519A
- Authority
- CA
- Canada
- Prior art keywords
- radicals
- diphenylsilanes
- silane
- anticonvulsant
- hydrolyzable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- VDCSGNNYCFPWFK-UHFFFAOYSA-N diphenylsilane Chemical class C=1C=CC=CC=1[SiH2]C1=CC=CC=C1 VDCSGNNYCFPWFK-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 230000001773 anti-convulsant effect Effects 0.000 title description 14
- 239000001961 anticonvulsive agent Substances 0.000 title description 14
- 229960003965 antiepileptics Drugs 0.000 title description 13
- 206010010904 Convulsion Diseases 0.000 claims abstract description 27
- 230000036461 convulsion Effects 0.000 claims abstract description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 7
- 230000001629 suppression Effects 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000969 carrier Substances 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 5
- 238000001727 in vivo Methods 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 3
- 235000019198 oils Nutrition 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000010775 animal oil Substances 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 abstract description 17
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 229910000077 silane Inorganic materials 0.000 description 15
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 150000004756 silanes Chemical class 0.000 description 11
- OLLFKUHHDPMQFR-UHFFFAOYSA-N dihydroxy(diphenyl)silane Chemical compound C=1C=CC=CC=1[Si](O)(O)C1=CC=CC=C1 OLLFKUHHDPMQFR-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 239000008159 sesame oil Substances 0.000 description 5
- 235000011803 sesame oil Nutrition 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 4
- 241001279009 Strychnos toxifera Species 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 150000002009 diols Chemical class 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 229960005453 strychnine Drugs 0.000 description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 3
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000003179 convulsant agent Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 229960002900 methylcellulose Drugs 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 230000002920 convulsive effect Effects 0.000 description 2
- MROCJMGDEKINLD-UHFFFAOYSA-N dichlorosilane Chemical compound Cl[SiH2]Cl MROCJMGDEKINLD-UHFFFAOYSA-N 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010053398 Clonic convulsion Diseases 0.000 description 1
- 102100036727 Deformed epidermal autoregulatory factor 1 homolog Human genes 0.000 description 1
- 101710172577 Deformed epidermal autoregulatory factor 1 homolog Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000699694 Gerbillinae Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034308 Grand mal convulsion Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 229910007991 Si-N Inorganic materials 0.000 description 1
- 229910020175 SiOH Inorganic materials 0.000 description 1
- 229910006294 Si—N Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000002344 aminooxy group Chemical group [H]N([H])O[*] 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000002566 clonic effect Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- OSMIWEAIYFILPL-UHFFFAOYSA-N dibutoxy(diphenyl)silane Chemical compound C=1C=CC=CC=1[Si](OCCCC)(OCCCC)C1=CC=CC=C1 OSMIWEAIYFILPL-UHFFFAOYSA-N 0.000 description 1
- OSXYHAQZDCICNX-UHFFFAOYSA-N dichloro(diphenyl)silane Chemical compound C=1C=CC=CC=1[Si](Cl)(Cl)C1=CC=CC=C1 OSXYHAQZDCICNX-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000001282 organosilanes Chemical class 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- DQMZLTXERSFNPB-UHFFFAOYSA-N primidone Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NCNC1=O DQMZLTXERSFNPB-UHFFFAOYSA-N 0.000 description 1
- 229960002393 primidone Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- -1 silane compound Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58702975A | 1975-06-16 | 1975-06-16 | |
| US05/666,822 US4006226A (en) | 1975-06-16 | 1976-03-15 | Anticonvulsant diphenylsilanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1058519A true CA1058519A (en) | 1979-07-17 |
Family
ID=27079893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA252,085A Expired CA1058519A (en) | 1975-06-16 | 1976-05-10 | Anticonvulsant diphenylsilanes |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4006226A (https=) |
| JP (1) | JPS521038A (https=) |
| CA (1) | CA1058519A (https=) |
| DE (1) | DE2623248A1 (https=) |
| FR (1) | FR2314724A1 (https=) |
| IT (1) | IT1063763B (https=) |
| SE (1) | SE7605348L (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4494956A (en) * | 1982-12-14 | 1985-01-22 | Ciba-Geigy Corporation | Process for pad dyeing cellulosic textile materials |
| FR2725207B1 (fr) * | 1994-09-30 | 1996-11-29 | Exsymol Sa | Composes a base de silicium biologiquement actifs, leurs applications therapeutiques et cosmetiques |
| EP1583765A4 (en) * | 2002-11-18 | 2008-03-26 | Grenpharma Llc | COMPOSITIONS FOR THE TREATMENT AND / OR PREVENTION OF DISEASES CHARACTERIZED BY THE PRESENCE OF METALLIC IONS |
| US7595308B2 (en) | 2002-11-18 | 2009-09-29 | Grenpharma Llc | Compositions for treating and/or preventing diseases characterized by the presence of metal ions |
| AU2005299474A1 (en) * | 2004-10-22 | 2006-05-04 | Grenpharama Llc | Compositions for treating and/or preventing diseases characterized by the presence of the metal ions |
| KR100790732B1 (ko) | 2006-02-15 | 2008-01-02 | 삼성전기주식회사 | 신뢰성이 확보된 액체 렌즈용 절연액 및 그 절연액을사용한 액체 렌즈 |
-
1976
- 1976-03-15 US US05/666,822 patent/US4006226A/en not_active Expired - Lifetime
- 1976-05-10 CA CA252,085A patent/CA1058519A/en not_active Expired
- 1976-05-11 SE SE7605348A patent/SE7605348L/xx unknown
- 1976-05-24 DE DE19762623248 patent/DE2623248A1/de active Pending
- 1976-06-03 JP JP51065108A patent/JPS521038A/ja active Pending
- 1976-06-04 FR FR7617021A patent/FR2314724A1/fr active Granted
- 1976-06-09 IT IT24093/76A patent/IT1063763B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| US4006226A (en) | 1977-02-01 |
| FR2314724A1 (fr) | 1977-01-14 |
| IT1063763B (it) | 1985-02-11 |
| DE2623248A1 (de) | 1976-12-23 |
| SE7605348L (sv) | 1976-12-17 |
| JPS521038A (en) | 1977-01-06 |
| FR2314724B1 (https=) | 1978-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002088172B1 (en) | Pentapeptide compounds and uses related thereto | |
| HUP9802653A2 (hu) | Helyettesített imidazolidinszármazékok, eljárás előállításukra, valamint hatóanyagként ezeket tartalmazó gyógyszerkészítmények | |
| KR20010033811A (ko) | 2차 및 3차 아민을 함유하는 약제의 물에 용해가능한프로드럭 및 그것의 제조방법 | |
| ATE71625T1 (de) | Imidazoheterocyclische verbindungen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| KR920021523A (ko) | 신규한 우레아 유도체, 이의 제조 방법 및 이들을 함유하는 약제학적 조성물 | |
| ES8500275A1 (es) | Procedimiento de preparacion de los derivados de la xantina | |
| EP1165080A2 (en) | Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections | |
| CA1058519A (en) | Anticonvulsant diphenylsilanes | |
| KR900004737A (ko) | 삼환 사슬의 화합물 및 그 제조방법 | |
| EP0097446B1 (en) | Penicillin derivatives and process for preparation of the same | |
| KR880011157A (ko) | 헤테로사이클릭 화합물, 이의 제법 및 용도 | |
| KR930002329A (ko) | 특정한 헤테로아릴 치환된 하이드록실아민 유도체 | |
| ES8708142A1 (es) | Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos | |
| EP0198686A3 (en) | Anticonvulsant dioxolane methane sulfamates | |
| EP0100499A3 (en) | Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same | |
| US4039666A (en) | Anticonvulsant phenylsilanes | |
| EP0134582A3 (en) | Novel peptides and process for preparing the same and pharmaceutical composition | |
| ES480041A1 (es) | Procedimiento para preparar acido ciclohexilcarboxilico y sus derivados. | |
| FR2830252B1 (fr) | Nouveaux oligomeres d'urees, leur procede de preparation et compositions pharmaceutiques les contenant | |
| BG103861A (en) | 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds | |
| Wissner et al. | Prostaglandins and congeners. 25. Inhibition of gastric acid secretion. Replacement of the carboxylate moiety of a prostaglandin with a hydroxymethylketo functional group | |
| EP0089635A3 (en) | Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same | |
| DE60132339D1 (de) | Verbindungen in form homodimerer oder heterodimerer prodrugs; verfahren zur herstellung dieser prodrugs und deren pharmakologisch verträglichen salzen und verwendung von verbindungen in der behandlung von phosphodiesterase vermittelten krankheiten und funktionsstörungen | |
| CA1179372A (en) | 1-branched-alkyl-3-(2-haloethy)-3-nitrosoureas as novel antitumor agents | |
| EP0046379B1 (en) | 4-lower hydrocarbyl-3-phenoxypyridine-1-oxides, process for their production, compositions containing them, and their use |